-
Featured
A New Approach to Induced Hypertension for Large Vessel Stroke
Patients with large vessel stroke may be eligible for endovascular thrombectomy, but transfer to a comprehensive stroke center is often delayed. Mass General physicians have shared the algorithm they use for induced hypertension, a strategy to save viable brain tissue until reperfusion can occur.
-
Featured
Is LVIS Blue Stent Safe as an Adjunct to Coil Embolization of Intracranial Aneurysms?
Newer treatments for cerebral aneurysms have focused on reconstruction of the parent vessel lumen using flow diversion. A Mass General team retrospectively studied whether the LVIS Blue would act as a flow-diverting stent when used in conjunction with coil embolization for treatment of intracranial aneurysms.
-
Featured
Uniform Definition Proposed to Provide Better Care for ELVO Patients
Led by Mass General neurosurgeon Thabele Leslie-Mazwi, MD, a medical society has proposed a standard definition which can help qualify patients for urgent care treatment.
-
No Sex Differences in Outcomes After Endovascular Thrombectomy for LVO Stroke
In a real-world analysis of patients treated with endovascular thrombectomy for stroke due to emergent large vessel occlusion, Massachusetts General Hospital researchers found women and men had comparable reperfusion rates and 90-day functional outcomes, even though women were older and had more pre-stroke disability.
-
Risk Score for Early Brain Injury Predicts 90-Day Outcome of Nontraumatic Subarachnoid Hemorrhage
W. Taylor Kimberly, MD, PhD, chief of the Division of Neurocritical Care, and colleagues have created and validated a risk score based on markers of early brain injury that predicts the 90-day risk of poor functional outcome after nontraumatic subarachnoid hemorrhage.
-
Clonal Hematopoiesis of Indeterminate Potential Linked to Higher Risk of Stroke
By reviewing genomic data, cardiologists at Massachusetts General Hospital confirmed that somatic age-related mutations in myeloid-lineage blood cells, termed clonal hematopoiesis of indeterminate potential, is associated with an increased risk of stroke and found the risk is highest for hemorrhagic stroke, especially subarachnoid hemorrhage.
Stroke Contributors
-
Aman B. Patel, MD
Director of Cerebrovascular and Endovascular Neurosurgery, Co-Director of the Neuroendovascular Program
Recent Article
No Sex Differences in Outcomes After Endovascular Thrombectomy for LVO Stroke
-
James D. Rabinov, MD
Neurosurgeon
Recent Article
Multimodal Approach to Unruptured Cerebral Arteriovenous Malformations Tops ARUBA Outcomes
-
Lee H. Schwamm, MD
Vice Chairman, Department of Neurology, Division Chief, Stroke Services, Director, TeleStroke Service
Recent Article
Mass General Provides Innovative, Expanded Telemedicine in Response to COVID-19
-
Mark F. Conrad, MD
Director of Clinical Research, Division of Vascular and Endovascular Surgery, Assistant Program Director, Division of Vascular and Endovascular Surgery
Recent Article
Adverse Neck Anatomy Increases Risk of Late Type 1A Endoleaks
-
Mark R. Etherton, MD, PhD
Assistant in Neurology, MGH, Instructor Harvard Medical School
Recent Article
No Sex Differences in Outcomes After Endovascular Thrombectomy for LVO Stroke -
Natalia S. Rost, MD, MPH, FAAN
Chief of Stroke Division, Department of Neurology, Massachusetts General Hospital, Professor of Neurology, Harvard Medical School
Recent Article
No Sex Differences in Outcomes After Endovascular Thrombectomy for LVO Stroke
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.